BRIJ GUPTA: Open Payments
NPI 1174532543 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 20 payments from 12 companies in 2025. Trend: 2023 $831 · 2024 $472 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $271 |
| Intra-Sana Laboratories | 3 | $82 |
| GENZYME CORPORATION | 1 | $76 |
| GlaxoSmithKline, LLC. | 3 | $66 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Exact Sciences Corporation | 2 | $33 |
| Lilly USA, LLC | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Novo Nordisk Inc | 1 | $21 |
| PFIZER INC. | 1 | $21 |
Products named: REPATHA, UPLIZNA, RELTONE 200 MG, KEVZARA, TRELEGY ELLIPTA, LEQVIO, Cologuard Collection Kit, EVENITY.
Industry payments across CA — which companies pay providers there.
